Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2

Cancers (Basel). 2023 Jan 19;15(3):630. doi: 10.3390/cancers15030630.

Abstract

Background: Extensive research effort has been devoted to investigating the link between inflammation and PCa. However, this relationship remains unclear and controversial. The aim of our multi-center study was to investigate this association by histologically evaluating the distribution of PI and PCA in prostate biopsy cores from patients of eight referral centers in Italy.

Results: We evaluated 2220 cores from 197 patients; all the frustules were re-evaluated by dedicated pathologists retrospectively. Pathologists assigned IRANI scores and determined the positions of PIs; pathologists also re-evaluated the presence of PCa and relative ISUP grade. PCa was recorded in 749/2220 (33.7%). We divided this sample into a PCa PI group (634/749 cores [84.7%]) and a non-PCa + PI group (1157/1471 cores [78.7%]). We observed a statistically significant difference in the presence of inflammation among cores with cancer (p < 0.01). Moreover, periglandular inflammation was higher in the cores with neoplasia, while stromal inflammation was higher in cores without neoplasia (38.5% vs. 31.1% and 55.4% vs. 63.5% p < 0.01).

Conclusions: In our experience, there is evidence of an association between PI and PCa at a tissue level. Further studies are needed to confirm our findings and to identify patients who might benefit from target therapies to prevent PCa occurrence and/or progression.

Keywords: prostate biopsy; prostate cancer; prostate inflammation.

Grants and funding

Pros-IT CNR and Pros-IT2 are non-profit observational studies. Takeda Italia S.p.A. provided unconditional grants to the CNR, to cover the costs of the preparatory meetings, the meetings of the advisory committees and of the PIs, and the cost of developing a web platform for data entry.